share_log

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Borgeson Blake

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Borgeson Blake

Recursion Pharmaceuticals | 4：持股變動聲明-董事 Borgeson Blake
美股SEC公告 ·  08/23 06:50
牛牛AI助理已提取核心訊息
On August 20, 2024, Blake Borgeson, associated with Recursion Pharmaceuticals, Inc. [RXRX], completed a sale of 11,447 shares of the company's Class A Common Stock. The transaction was carried out on the open market at a price of $7.1226 per share, resulting in a total sale value of approximately $81,532.40. Following this transaction, Borgeson directly holds a total of 7,132,769 shares in Recursion Pharmaceuticals.
On August 20, 2024, Blake Borgeson, associated with Recursion Pharmaceuticals, Inc. [RXRX], completed a sale of 11,447 shares of the company's Class A Common Stock. The transaction was carried out on the open market at a price of $7.1226 per share, resulting in a total sale value of approximately $81,532.40. Following this transaction, Borgeson directly holds a total of 7,132,769 shares in Recursion Pharmaceuticals.
2024年8月20日，與Recursion Pharmaceuticals Inc. [RXRX] 相關聯的Blake Borgeson完成了對該公司A類普通股的11,447股的出售。本次交易是在開放市場上以每股7.1226美元的價格進行的，總計以近$81,532.40進行了出售。在此交易之後，Borgeson在Recursion Pharmaceuticals中直接持有總計7,132,769股。
2024年8月20日，與Recursion Pharmaceuticals Inc. [RXRX] 相關聯的Blake Borgeson完成了對該公司A類普通股的11,447股的出售。本次交易是在開放市場上以每股7.1226美元的價格進行的，總計以近$81,532.40進行了出售。在此交易之後，Borgeson在Recursion Pharmaceuticals中直接持有總計7,132,769股。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    熱議
    美股
    股票代碼最新價升跌幅

    暫無數據

    資訊熱榜
    更新時間